A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)

Administered By

Awarded By

Contributors

Start/End

  • April 29, 2021 - February 28, 2026